Subscribe To
Virios Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
ATLANTA, May 25, 2023 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a clinical‐stage biopharmaceutical company, today announced that it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. Below are some recent key developments in the business, including the Company regaining compliance with the […] The post Virios Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement appeared first o...
Read More
Posted: May 25 2023, 20:05
Author Name: forextv
Views: 110746